171 related articles for article (PubMed ID: 37071267)
1. Malignant phyllodes tumors of the breast: the malignancy grading and associations with prognosis.
Liu J; Li F; Liu X; Lang R; Liang R; Lu H
Breast Cancer Res Treat; 2023 Jun; 199(3):435-444. PubMed ID: 37071267
[TBL] [Abstract][Full Text] [Related]
2. Retrospective study of malignant phyllodes tumors of the breast: Younger age, prior fibroadenoma surgery, malignant heterologous elements and surgical margins may predict recurrence.
Li Y; Song Y; Lang R; Shi L; Gao S; Liu H; Wang P
Breast; 2021 Jun; 57():62-70. PubMed ID: 33774460
[TBL] [Abstract][Full Text] [Related]
3. Predictive factors for the local recurrence and distant metastasis of phyllodes tumors of the breast: a retrospective analysis of 192 cases at a single center.
Wei J; Tan YT; Cai YC; Yuan ZY; Yang D; Wang SS; Peng RJ; Teng XY; Liu DG; Shi YX
Chin J Cancer; 2014 Oct; 33(10):492-500. PubMed ID: 25104281
[TBL] [Abstract][Full Text] [Related]
4. Size and heterologous elements predict metastases in malignant phyllodes tumours of the breast.
Koh VCY; Thike AA; Nasir NDM; Yip GWC; Bay BH; Tan PH
Virchows Arch; 2018 Apr; 472(4):615-621. PubMed ID: 29127495
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors in phyllodes tumours of the breast: retrospective study on 166 consecutive cases.
Di Liso E; Bottosso M; Lo Mele M; Tsvetkova V; Dieci MV; Miglietta F; Falci C; Faggioni G; Tasca G; Giorgi CA; Giarratano T; Mioranza E; Michieletto S; Saibene T; Dei Tos AP; Conte P; Guarneri V
ESMO Open; 2020 Oct; 5(5):e000843. PubMed ID: 33020219
[TBL] [Abstract][Full Text] [Related]
6. High expression of microRNA20b is associated with malignant clinicopathological features and poor prognosis in breast phyllodes tumor.
Lei T; Yin L; Zhang H; Wei B; Chen H; Pu T; Yang L; Ye F; Zhang Z; Bu H
Int J Clin Oncol; 2020 Dec; 25(12):2025-2034. PubMed ID: 32803488
[TBL] [Abstract][Full Text] [Related]
7. Phyllodes tumor of the breast: stromal overgrowth and histological classification are useful prognosis-predictive factors for local recurrence in patients with a positive surgical margin.
Taira N; Takabatake D; Aogi K; Ohsumi S; Takashima S; Nishimura R; Teramoto N
Jpn J Clin Oncol; 2007 Oct; 37(10):730-6. PubMed ID: 17932112
[TBL] [Abstract][Full Text] [Related]
8. Pediatric Malignant Phyllodes Tumors of the Breast: Characteristics and Outcomes Based on the Surveillance Epidemiology and End Results Database.
Xiao Y; Jiang Y; Xiong Y; Ruan S; Huang T
J Surg Res; 2020 May; 249():205-215. PubMed ID: 31991330
[TBL] [Abstract][Full Text] [Related]
9. [Histologic classification and prognosis factors in phyllodes tumors of breast].
Jia C; Mei F; Liu JY; Zhao HM; Lei YT; Su J; Huang SS; Zheng J; You JF
Zhonghua Bing Li Xue Za Zhi; 2017 Jan; 46(1):14-19. PubMed ID: 28072970
[No Abstract] [Full Text] [Related]
10. Phyllodes tumor of the breast: a retrospective study of the impact of histopathological factors in local recurrence and distant metastasis.
Sawalhi S; Al-Shatti M
Ann Saudi Med; 2013; 33(2):162-8. PubMed ID: 23563006
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Outcomes After Surgical Treatment of Malignant/Borderline Phyllodes Tumors of the Breast.
Spanheimer PM; Murray MP; Zabor EC; Stempel M; Morrow M; Van Zee KJ; Barrio AV
Ann Surg Oncol; 2019 Jul; 26(7):2136-2143. PubMed ID: 30783853
[TBL] [Abstract][Full Text] [Related]
12. [Prognostic analysis of benign, borderline and malignant phyllodes tumors of the breast].
Wang H; Wang X; Wang C
Zhonghua Zhong Liu Za Zhi; 2015 Dec; 37(12):923-7. PubMed ID: 26887622
[TBL] [Abstract][Full Text] [Related]
13. Phyllodes tumors of the breast: clinicopathological analysis of 106 cases from a single institution.
Efared B; Ebang GA; Tahiri L; Sidibé IS; Erregad F; Hammas N; Melhouf MA; Banani A; Chbani L; Fatemi HE
Breast Dis; 2018; 37(3):139-145. PubMed ID: 29332027
[TBL] [Abstract][Full Text] [Related]
14. Expression of cancer stem cell markers in breast phyllodes tumor.
Kim SI; Koo JS
Cancer Biomark; 2020; 29(2):235-243. PubMed ID: 32675396
[TBL] [Abstract][Full Text] [Related]
15. Analysis of phyllodes tumor recurrence according to the histologic grade.
Kim S; Kim JY; Kim DH; Jung WH; Koo JS
Breast Cancer Res Treat; 2013 Oct; 141(3):353-63. PubMed ID: 24062207
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological study on phyllodes tumor of the breast.
Shi F; Ye H; Chai Z;
Zhonghua Bing Li Xue Za Zhi; 2002 Jun; 31(3):208-12. PubMed ID: 12475436
[TBL] [Abstract][Full Text] [Related]
17. In phyllodes tumour of the breast expression of c-kit but not of ALDH1A1 is associated with adverse clinico-pathological features.
Chougule A; Bal A; Das A; Kohli PS; Singh G
Virchows Arch; 2016 Dec; 469(6):651-658. PubMed ID: 27696244
[TBL] [Abstract][Full Text] [Related]
18. Surgical treatment of phyllodes tumors of the breast: retrospective review of 172 cases.
Chen WH; Cheng SP; Tzen CY; Yang TL; Jeng KS; Liu CL; Liu TP
J Surg Oncol; 2005 Sep; 91(3):185-94. PubMed ID: 16118768
[TBL] [Abstract][Full Text] [Related]
19. Phyllodes tumor of the prostate: long-term followup study of 23 cases.
Bostwick DG; Hossain D; Qian J; Neumann RM; Yang P; Young RH; di Sant'agnese PA; Jones EC
J Urol; 2004 Sep; 172(3):894-9. PubMed ID: 15310992
[TBL] [Abstract][Full Text] [Related]
20. [Prognosis analysis of local recurrence after excision of breast phyllodes tumors].
Peng Y; Zhang YY; Wang SC; Wu JB; Tong FZ; Liu P; Cao YM; Zhou B; Cheng L; Liu M; Liu HJ; Guo JJ; Xie F; Yang HP; Wang SY; Wang CB; Wang S
Zhonghua Wai Ke Za Zhi; 2021 Feb; 59(2):116-120. PubMed ID: 33378803
[No Abstract] [Full Text] [Related]
[Next] [New Search]
